Literature DB >> 8921010

Type VIII collagen is a product of vascular smooth-muscle cells in development and disease.

J R MacBeath1, C M Kielty, C A Shuttleworth.   

Abstract

Type VIII collagen is a short-chain collagen with considerable similarity to type X collagen. We have generated chain-specific antibodies to the alpha 1 and alpha 2 chains of type VIII collagen, and used them as probes to examine the synthesis of type VIII collagen by vascular smooth muscle cells (VSMC). In addition, chain-specific oligonucleotides have been used in reverse transcriptase-PCR (RT-PCR) reactions with RNA extracted from cultured smooth muscle cells in culture and from freshly isolated vascular tissues. Radiolabelling of VSMC in culture and immunoprecipitation with chain-specific antibodies showed that both chains were expressed. Lower levels of type VIII collagen were found in adult VSMC than in neonatal VSMC. RT-PCR showed that both chains were expressed in tissues as well as cells in culture. The results indicate that type VIII collagen is a product of VSMC of normal adult vessels and is expressed at high levels by VSMC in vascular lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921010      PMCID: PMC1217886          DOI: 10.1042/bj3190993

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Radiolabeling of proteins by reductive alkylation with [14C]formaldehyde and sodium cyanoborohydride.

Authors:  D Dottavio-Martin; J M Ravel
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

Review 4.  Collagens: molecular biology, diseases, and potentials for therapy.

Authors:  D J Prockop; K I Kivirikko
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  Biosynthetic and structural properties of endothelial cell type VIII collagen.

Authors:  H Sage; B Trüeb; P Bornstein
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

6.  EC collagen: biosynthesis by corneal endothelial cells and separation from type IV without pepsin treatment or denaturation.

Authors:  P D Benya
Journal:  Ren Physiol       Date:  1980

7.  A unique, pepsin-sensitive collagen synthesized by aortic endothelial cells in culture.

Authors:  H Sage; P Pritzl; P Bornstein
Journal:  Biochemistry       Date:  1980-12-09       Impact factor: 3.162

8.  Biosynthesis of an unusual collagen type by human astrocytoma cells in vitro.

Authors:  K Alitalo; P Bornstein; A Vaheri; H Sage
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

9.  Type VIII collagen. Synthesis by normal and malignant cells in culture.

Authors:  H Sage; G Balian; A M Vogel; P Bornstein
Journal:  Lab Invest       Date:  1984-02       Impact factor: 5.662

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  8 in total

1.  The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair.

Authors:  G Hou; W Vogel; M P Bendeck
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury.

Authors:  G Hou; D Mulholland; M A Gronska; M P Bendeck
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

3.  Upregulation of collagen VIII following porcine coronary artery angioplasty is related to smooth muscle cell migration not angiogenesis.

Authors:  S Sinha; C M Kielty; A M Heagerty; A E Canfield; C A Shuttleworth
Journal:  Int J Exp Pathol       Date:  2001-10       Impact factor: 1.925

4.  Gene expression patterns related to vascular invasion and aggressive features in endometrial cancer.

Authors:  Monica Mannelqvist; Ingunn M Stefansson; Geir Bredholt; Trond Hellem Bø; Anne M Oyan; Inge Jonassen; Karl-Henning Kalland; Helga B Salvesen; Lars A Akslen
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

5.  Comparative gene array analyses of severe elastic fiber defects in late embryonic and newborn mouse aorta.

Authors:  Marius Catalin Staiculescu; Austin J Cocciolone; Jesse D Procknow; Jungsil Kim; Jessica E Wagenseil
Journal:  Physiol Genomics       Date:  2018-10-12       Impact factor: 3.107

6.  Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits.

Authors:  Sohsuke Yamada; Ke-Yong Wang; Akihide Tanimoto; Jianglin Fan; Shohei Shimajiri; Shuji Kitajima; Masatoshi Morimoto; Masato Tsutsui; Teruo Watanabe; Kosei Yasumoto; Yasuyuki Sasaguri
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

7.  Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis.

Authors:  Joshua Lopes; Eser Adiguzel; Steven Gu; Shu-Lin Liu; Guangpei Hou; Scott Heximer; Richard K Assoian; Michelle P Bendeck
Journal:  Am J Pathol       Date:  2013-04-06       Impact factor: 4.307

8.  Deletion of type VIII collagen reduces blood pressure, increases carotid artery functional distensibility and promotes elastin deposition.

Authors:  Amanda L Mohabeer; Jeffrey T Kroetsch; Meghan McFadden; Negin Khosraviani; Thomas J Broekelmann; Guangpei Hou; Hangjun Zhang; Yu-Qing Zhou; Minyao Wang; Anthony O Gramolini; Robert P Mecham; Scott P Heximer; Steffen-Sebastian Bolz; Michelle P Bendeck
Journal:  Matrix Biol Plus       Date:  2021-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.